Novavax Inc. plans to progress its Covid-19 vaccine candidate with new additions to the company and about $200 million from selling convertible preferred stock to an RA Capital Management investment fund — the latest cash infusion for the Montgomery County vaccine maker. The preferred private placement with the Boston firm, which closed June 16, came less than two weeks after Novavax (NASDAQ: NVAX) won a Department of Defense contract worth up to $60 million to help manufacture its coronavirus…
from https://www.bizjournals.com/baltimore/news/2020/06/23/novavax-charges-ahead-with-200m-in-capital.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/621713044970635264
No comments:
Post a Comment